HER2-positive BC exhibits a distinct immunosuppressive phenotype characterized by hormone signaling-mediated suppression of antigen presentation, enhanced infiltrating of immunosuppressive cells, and depleted TILs population, thus, traditional immune indicators such as TILs have limited value in predicting its survival (96, 97). The gene discussed is ERBB2; the disease is breast cancer.